June 30, 2020

Goldfinch Bio

Goldfinch Bio Secures $100 Million in Series B Financing

June 29, 2020

Blueprint Medicines

Blueprint Medicines Announces Publication in The Lancet Oncology Showing Durable Clinical Benefits of AYVAKIT™ (avapritinib) in NAVIGATOR Trial Patients with PDGFRA D842V Mutant GIST

June 25, 2020

GBT

GBT Awards $250,000 in ACCEL Grants to Advance Access to Care for People Living with Sickle Cell Disease

June 25, 2020

Nurix

Nurix Therapeutics Announces Formation Of DeCART Therapeutics To Advance New CAR T Therapies Using Targeted Protein Modulation

June 24, 2020

Fulcrum Therapeutics

Fulcrum Therapeutics Announces Initiation of Multi-Center Phase 3 (LOSVID) Trial with Losmapimod for Hospitalized COVID-19 Patients

Load More

Sign up for weekly portfolio news.